| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $53.43 | $1,068,600.00 | -5.4% | +5.3% | +16.0% | |
| Jun 30, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 164,125 | $467.60 | $76,744,390.23 | - | +16.1% | +93.1% | |
| Jun 30, 2023 | CGC Canopy Growth Corp | Klein David Eric55 | Chief Executive Officer | Sell | 18,775 | $0.52 | $9,763.00 | -9.8% | +109.7% | +66.3% | |
| Jun 30, 2023 | CGC Canopy Growth Corp | Hong Judy Eun Joo66 | Chief Financial Officer | Sell | 1,087 | $0.52 | $565.24 | -21.3% | +109.7% | +66.3% | |
| Jun 29, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 44,115 | $465.08 | $20,517,136.55 | - | +18.4% | +94.9% | |
| Jun 29, 2023 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 23,282 | $9.02 | $210,117.72 | -100% | -31.6% | +122.1% | |
| Jun 29, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 85,729 | $9.01 | $772,023.94 | -33.8% | -31.6% | +122.1% | |
| Jun 28, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Director, 10% Owner | Buy | 800,002 | $1.50 | $1,200,003.00 | +0.9% | - | - | |
| Jun 28, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 11,760 | $465.41 | $5,473,168.20 | - | +19.9% | +98.2% | |
| Jun 28, 2023 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 22,877 | $2.87 | $65,604.01 | -29.2% | - | - | |
| Jun 27, 2023 | CGC Canopy Growth Corp | Stewart Thomas Carlton45 | Chief Accounting Officer | Sell | 19,667 | $0.62 | $12,193.54 | -58.0% | +98.9% | +39.9% | |
| Jun 27, 2023 | CGC Canopy Growth Corp | Schmeling Judy56 | Director | Sell | 1,859 | $0.62 | $1,152.58 | -3.2% | +98.9% | +39.9% | |
| Jun 27, 2023 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 3,856 | $0.62 | $2,390.72 | -15.3% | +98.9% | +39.9% | |
| Jun 27, 2023 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 3,872 | $0.62 | $2,400.64 | -18.4% | +98.9% | +39.9% | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | McDermott Edward Aloysious III | Chief Operating Officer | Sell | 4,369 | $2.92 | $12,735.64 | -10.2% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Thompson Destiny Lynn | Chief People Officer | Sell | 5,886 | $2.91 | $17,157.69 | -20.8% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | General Counsel | Sell | 5,747 | $2.92 | $16,752.51 | -12.5% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Archos George Peter | Chief Executive Officer | Sell | 18,286 | $2.92 | $53,303.69 | -2.6% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Miles Aaron Nathaniel | Chief Investment Officer | Sell | 11,581 | $2.92 | $33,758.62 | -12.4% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Spreckman David | Chief Marketing Officer | Sell | 7,116 | $2.92 | $20,743.14 | -18.1% | - | - | |
| Jun 27, 2023 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 23,691 | $2.92 | $69,059.27 | -3.6% | - | - | |
| Jun 26, 2023 | COLL Collegium Pharmaceutical, Inc | Kuhlmann Shirley R.49 | EVP And General Counsel | Sell | 17,984 | $21.72 | $390,632.85 | -7.0% | +4.9% | +47.9% | |
| Jun 23, 2023 | TSNDF Terrascend Corp. | Stauffer Keith | CFO | Buy | 700 | $0.00 | - | New | - | - | |
| Jun 22, 2023 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $51.32 | $1,026,400.00 | -5.1% | +17.4% | +13.6% | |
| Jun 22, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 107,022 | $459.28 | $49,153,574.25 | - | +24.5% | +93.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.